AGP Picks
View all

Africa Daily Journal
Provided by AGP

Africa Daily Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa Daily Journal.

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

Press releases published on June 16, 2026

Charlotte to Host Global Africa Summit 2026: 300+ Leaders to Advance U.S.–Africa Trade, Investment & Economic Resilience
Jun. 16, 2026

Charlotte to Host Global Africa Summit 2026: 300+ Leaders to Advance U.S.–Africa Trade, Investment & Economic Resilience

Indeterminate EIN Presswire
AFRETRADE hosts ARIYA NETWORKS CEO, Callifornia State Secretary of Transportation, and others at TAEF in Lagos
Jun. 16, 2026

AFRETRADE hosts ARIYA NETWORKS CEO, Callifornia State Secretary of Transportation, and others at TAEF in Lagos

Indeterminate EIN Presswire
Yorbeau Resources Inc. Announces Election of Directors
Jun. 16, 2026

Yorbeau Resources Inc. Announces Election of Directors

Indeterminate GlobeNewswire
Les Ressources Yorbeau Inc. annonce les résultats du vote pour l’élection des administrateurs
Jun. 16, 2026

Les Ressources Yorbeau Inc. annonce les résultats du vote pour l’élection des administrateurs

Indeterminate GlobeNewswire
1911 Gold Announces $20 Million Bought Deal Financing
Jun. 16, 2026

1911 Gold Announces $20 Million Bought Deal Financing

Indeterminate GlobeNewswire
Johnson Matthey selected by Phelan Green for landmark e-SAF plant in South Africa
Jun. 16, 2026

Johnson Matthey selected by Phelan Green for landmark e-SAF plant in South Africa

Indeterminate EIN Presswire
Shopify Announces Results of its 2026 Annual Meeting of Shareholders
Jun. 16, 2026

Shopify Announces Results of its 2026 Annual Meeting of Shareholders

Indeterminate GlobeNewswire
More Antimony Intersections on the Bald Hill Main Zone
Jun. 16, 2026

More Antimony Intersections on the Bald Hill Main Zone

Indeterminate GlobeNewswire
Nova Minerals Announces Completion of its Redomiciliation to the United States
Jun. 16, 2026

Nova Minerals Announces Completion of its Redomiciliation to the United States

Indeterminate GlobeNewswire
Brain Cancer Innovator NeOnc Heads into Critical Data Season with Fresh Abu Dhabi IND
Jun. 16, 2026

Brain Cancer Innovator NeOnc Heads into Critical Data Season with Fresh Abu Dhabi IND

Indeterminate GlobeNewswire
Globex Mining Enterprises Inc. Reports High-Grade Gold Intersections at Duquesne West
Jun. 16, 2026

Globex Mining Enterprises Inc. Reports High-Grade Gold Intersections at Duquesne West

Indeterminate GlobeNewswire
Creative Medical Technology Holdings, Inc. Advances Project PHOENIX into Nationwide AI Driven Virtual Data Collection Phase for U.S. Veterans Exposed to Burn Pits and Toxic Hazards
Jun. 16, 2026

Creative Medical Technology Holdings, Inc. Advances Project PHOENIX into Nationwide AI Driven Virtual Data Collection Phase for U.S. Veterans Exposed to Burn Pits and Toxic Hazards

Indeterminate GlobeNewswire
AnorTech and Greenland Mines Enter Into Strategic Share Exchange Agreement
Jun. 16, 2026

AnorTech and Greenland Mines Enter Into Strategic Share Exchange Agreement

Indeterminate GlobeNewswire
Oncolytics Biotech® Secures New U.S. Patent Protecting Commercial Manufacturing of Pelareorep into 2044
Jun. 16, 2026

Oncolytics Biotech® Secures New U.S. Patent Protecting Commercial Manufacturing of Pelareorep into 2044

Indeterminate GlobeNewswire
Quoin Pharmaceuticals Announces Positive Clinical Update from Ongoing Pediatric Netherton Syndrome Compassionate Use Program
Jun. 16, 2026

Quoin Pharmaceuticals Announces Positive Clinical Update from Ongoing Pediatric Netherton Syndrome Compassionate Use Program

Indeterminate GlobeNewswire
Outlook Therapeutics Announces FDA Acceptance of Resubmitted Biologics License Application for ONS-5010/LYTENAVA™ (bevacizumab-vikg) as a Treatment for Wet AMD
Jun. 16, 2026

Outlook Therapeutics Announces FDA Acceptance of Resubmitted Biologics License Application for ONS-5010/LYTENAVA™ (bevacizumab-vikg) as a Treatment for Wet AMD

Indeterminate GlobeNewswire
ConSynance Therapeutics Announces First Patient Dosed in Phase 2a Clinical Trial of CSTI-500 for Prader-Willi Syndrome
Jun. 16, 2026

ConSynance Therapeutics Announces First Patient Dosed in Phase 2a Clinical Trial of CSTI-500 for Prader-Willi Syndrome

Indeterminate GlobeNewswire
BioAge Labs Announces First Participant Dosed in QUELL-CV, a Phase 2 Proof-of-Concept Trial of BGE-102, a Novel Oral NLRP3 Inhibitor, in Patients at Elevated Cardiovascular Risk
Jun. 16, 2026

BioAge Labs Announces First Participant Dosed in QUELL-CV, a Phase 2 Proof-of-Concept Trial of BGE-102, a Novel Oral NLRP3 Inhibitor, in Patients at Elevated Cardiovascular Risk

Indeterminate GlobeNewswire
Vaxart’s Two Newest Independent Directors James Breitmeyer, M.D., Ph.D., and Kevin Finney Send Letter to Shareholders Ahead of 2026 Annual Meeting
Jun. 16, 2026

Vaxart’s Two Newest Independent Directors James Breitmeyer, M.D., Ph.D., and Kevin Finney Send Letter to Shareholders Ahead of 2026 Annual Meeting

Indeterminate GlobeNewswire
Clearmind Medicine Completes Dosing for Part A of its of FDA-Regulated Phase I/II Clinical Trial
Jun. 16, 2026

Clearmind Medicine Completes Dosing for Part A of its of FDA-Regulated Phase I/II Clinical Trial

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Africa Daily Journal

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.